The Regional Sales Manager is focused on business development. Driven by the new number of patient acquisition, the RSM is responsible for new contract development and is the privileged contact for doctors and clinics and the RSM is responsible for their satisfaction state.
Main activities
Main tasks
Extra activities
Profile
Bachelor or Master Degree
At least 4 years of sales experience with medical devices or in pharmaceutical environment
Existing network in pneumology - sleep stakeholders in the region
Knowledge of Oxygen, sleep, ventilation, diabetes environment
Fluent in Flemish - French - English
Customer - patient centered mindset and strong negotiation skills
Understanding Tender process
Teamplayer
Energetic and driven attitude
Result and data driven mindset
Hard & soft skills
Sales & business dev. Strategy
Knowledge of Tender Business
Negotiation
Results focused
Resilient
Positive
Communication
Adapt to change
Good presentation appearance
Medical device and services knowledge
Good with different IT tools
Extra information
Responsible for the East and West Flanders region.
The office is situated in Zemst.
Our Differences make our Performance
At Air Liquide, we are committed to build a diverse and inclusive workplace that embraces the diversity of our employees, our customers, patients, community stakeholders and cultures across the world.
We welcome and consider applications from all qualified applicants, regardless of their background. We strongly believe a diverse organization opens up opportunities for people to express their talent, both individually and collectively and it helps foster our ability to innovate by living our fundamentals, acting for our success and creating an engaging environment in a changing world.

Air Liquide is a world leader in gases, technologies and services for industry and healthcare. Present in 72 countries with 67,800 employees, the Group serves more than 4 million customers and patients. Oxygen, nitrogen and hydrogen are essential small molecules for life, matter and energy. They embody Air Liquide’s scientific territory and have been at the core of the Group’s activities since its creation in 1902.
Taking action today while preparing the future is at the heart of Air Liquide’s strategy. With ADVANCE, its strategic plan for 2025, Air Liquide is targeting a global performance, combining financial and extra-financial dimensions. Positioned on new markets, the Group benefits from major assets such as its business model combining resilience and strength, its ability to innovate and its technological expertise. The Group develops solutions contributing to climate and the energy transition—particularly with hydrogen—and takes action to progress in areas of healthcare, digital and high technologies.
Air Liquide’s revenue amounted to more than 27.5 billion euros in 2023. Air Liquide is listed on the Euronext Paris stock exchange (compartment A) and belongs to the CAC 40, CAC 40 ESG, EURO STOXX 50, FTSE4Good and DJSI Europe indexes.